Do you want to read an article? Please log in or register.
Rituximab in patients with pediatric multiple sclerosis and other demyelinating disorders of the CNS: Practical considerations
Multiple Sclerosis
RECOMMENDED
Related content
Multiple Sclerosis
The Use of Natalizumab in Pediatric Patients With Active Relapsing Multiple Sclerosis: A Prospective Study
Pediatr Neurol.
Alroughani R, Ahmed SF, Behbehani R, Al-Hashel J
doi: 10.1016/
Multiple Sclerosis
Association of Rituximab Treatment With Disability Progression Among Patients With Secondary Progressive Multiple Sclerosis
JAMA Neurol.
Naegelin Y, Naegelin P, von Felten S, Lorscheider J, Sonder J, Uitdehaag BMJ, Scotti B, Zecca C, Gobbi C, Kappos L, Derfuss T
doi: 10.1001/jamaneurol.
SPECIAL REPORT
Multiple Sclerosis
Vaccination Readiness in Multiple Sclerosis
RECOMMENDED
Multiple Sclerosis
Spinal cord involvement in multiple sclerosis and neuromyelitis optica spectrum disorders
Lancet Neurol.
Ciccarelli O, Cohen JA, Reingold SC, Weinshenker BG; International Conference on Spinal Cord Involvement and Imaging in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorders
doi: 10.1016/S1474-
Multiple Sclerosis
Factors influencing patient satisfaction with the first diagnostic consultation in multiple sclerosis: a Swiss Multiple Sclerosis Registry (SMSR) study.
J Neurol.
Kamm CP, Barin L, Gobbi C, Pot C, Calabrese P, Salmen A, Achtnichts L, Kesselring J, Puhan MA, von Wyl V, Swiss Multiple Sclerosis Registry (SMSR).
doi: 10.1007/s00415-019-09563-y.
RECOMMENDED
Multiple Sclerosis
Comparison of rituximab originator (MabThera®) to biosimilar (Truxima®) in patients with multiple sclerosis
★ 2
Recommended by
Prof. Dr Claudio Gobbi, Faculty Member
Mult Scler.
Perez T, Rico A, Boutière C, Maarouf A, Roudot M, Honoré S, Pelletier J, Bertault-Peres P, Audoin B
doi: 10.1177/1352458520912170.
Multiple Sclerosis
Increased interleukin-27 cytokine expression in the central nervous system of multiple sclerosis patients
J Neuroinflammation.
Lalive PH, Kreutzfeldt M, Devergne O, Metz I, Bruck W, Merkler D, Pot C
doi: 10.1186/s12974-017-0919-1.
RECOMMENDED
EpilepsyMultiple Sclerosis
Trial of Fingolimod versus Interferon Beta-1a in Pediatric Multiple Sclerosis
N Engl J Med.
Chitnis T, Arnold DL, Banwell B, Brück W, Ghezzi A, Giovannoni G, Greenberg B, Krupp L, Rostásy K, Tardieu M, Waubant E, Wolinsky JS, Bar-Or A, Stites T, Chen Y, Putzki N, Merschhemke M, Gärtner J, PARADIGMS Study Group
doi: 10.1056/NEJMoa1800149.
Multiple Sclerosis
Natalizumab, rituximab and fingolimod as escalation therapy in multiple sclerosis
Eur J Neurol.
Boremalm M, Juto A, Axelsson M, Novakova L, Frisell T, Svenningsson A, Lycke J, Piehl F, Salzer J
doi: 10.1111/ene.13936.